Skip to main content
Livermore
Livermore
ZHEN

Cullinan Therapeutics, Inc.

CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789972

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Cullinan Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CGEM: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders144145+1
Shares62.6M61.1M−1.53M (−2.4%)
Value$471.4M$362.2M−$109.3M (−23.2%)

New holders (27)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CGEM in Q3 2025
InstitutionSharesValue% of portfolio
Cubist Systematic Strategies, LLC222,318$1.32M0.02%
Jump Financial, LLC194,507$1.15M0.01%
Susquehanna Portfolio Strategies, LLC124,531$738.5K0.01%
Two Sigma Investments, LP59,672$353.9K0.00%
Oxford Asset Management LLP56,486$335.0K0.11%
Quantinno Capital Management LP49,525$293.7K0.00%
HRT Financial LP42,109$249.0K0.00%
Two Sigma Advisers, LP37,300$221.2K0.00%
Axq Capital, LP32,669$193.7K0.07%
Magnetar Financial LLC26,263$155.7K0.00%
Fox Run Management, L.L.C.15,528$92.1K0.01%
Pale Fire Capital SE14,615$86.7K0.01%
Quadrature Capital Ltd13,942$82.7K0.00%
Compass Ion Advisors, LLC13,904$82.5K0.01%
Inscription Capital, LLC11,284$66.9K0.01%
SG Americas Securities, LLC10,466$62.0K0.00%
Federation des caisses Desjardins du Quebec6,000$35.6K0.00%
Point72 (DIFC) Ltd3,553$21.1K0.00%
Aquatic Capital Management LLC2,782$16.5K0.00%
SRS Capital Advisors, Inc.1,440$8.54K0.00%
FNY Investment Advisers, LLC1,365$8.00K0.00%
Quadrant Capital Group LLC904$5.36K0.00%
Optiver Holding B.V.464$2.75K0.00%
Clearstead Advisors, LLC49$2910.00%
True Wealth Design, LLC36$2140.00%
Massmutual Trust Co FSB27$1600.00%
Colony Group, LLC3,498––

Sold out (26)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of CGEM in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Patient Square Capital LP868,897$6.54M
Rock Springs Capital Management LP668,233$5.03M
Foresite Capital Management VI LLC594,025$4.47M
Verition Fund Management LLC139,660$1.05M
NEOS Investment Management LLC42,692$321.5K
Tema ETFs LLC42,692$321.5K
HighVista Strategies LLC31,893$240.2K
Nebula Research & Development LLC31,853$239.9K
Man Group plc22,341$168.2K
Martingale Asset Management L P20,932$157.6K
Palumbo Wealth Management LLC17,008$128.1K
Commonwealth Equity Services, LLC14,699$111.0K
Voya Investment Management LLC14,661$110.4K
ExodusPoint Capital Management, LP13,988$105.0K
Massar Capital Management, LP13,418$101.0K
State of Wisconsin Investment Board11,173$84.1K
Y-Intercept (Hong Kong) Ltd11,129$83.8K
Skopos Labs, Inc.3,665$27.6K
Advisor Group Holdings, Inc.2,115$15.9K
Federated Hermes, Inc.1,495$11.3K
Bessemer Group Inc436$3.00K
US Bancorp295$2.22K
Washington Trust Advisors, Inc.127$956
MAI Capital Management76$573
Larson Financial Group LLC56$422
Versant Capital Management, Inc23$173